Siggi’s — Mixed Berries Plant-based Coconut Blend, Mixed Berries
by SIGGI'SMRT 176 Panel Triggers Identified
Clinical Product Assessment
Siggi’s manufactures this product, which has been analyzed against the full MRT 176 panel — comprising 149 foods and 27 chemical additives — to identify potential immune-mediated sensitivities.
MRT Safety Assessment
This product contains 6 MRT-tested substances: Coconut (found in milk, cream, and oil), Green Pea (as pea protein), Raspberry, Strawberry, Cane Sugar, and Tapioca. Additionally, the presence of ‘natural flavor’ introduces unknown variables. Due to the high number of triggers, this product is contraindicated for Phase 1 and Phase 2. Patients should only consume this under the guidance of a practitioner after individual ingredients have been cleared. This is procedural data interpretation, not medical guidance.
Risk Summary
- Risk Classification: High Risk
- MRT Triggers Identified: 6
- Safe Ingredients: 5
- Unknown/Ambiguous: 1 (natural flavor)
- LEAP Phase Compatibility: Phase 3 — Practitioner Guided
Flagged Ingredient Mapping
The following ingredients were identified as matching substances on the MRT 176 panel. Each ingredient is mapped to its corresponding panel analyte:
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| coconut milk | Coconut | Direct Match |
| coconut cream | Coconut | Direct Match |
| pea protein | Green Pea | Direct Match |
| raspberries | Raspberry | Direct Match |
| strawberries | Strawberry | Direct Match |
| cane sugar | Cane Sugar | Direct Match |
| coconut oil | Coconut | Direct Match |
| tapioca flour | Tapioca | Direct Match |
Unknown / Ambiguous Ingredients
The following ingredients could not be definitively mapped to the MRT 176 panel and may contain hidden triggers: natural flavor. Patients should treat these as potential triggers until MRT testing confirms safety. Common examples include ‘natural flavors’ (which can contain any of the 176 tested substances) and ‘spices’ (which may include tested spices like cinnamon, cumin, or black pepper).
LEAP Protocol Guidance
With 6 MRT-tested substances identified, this product is not recommended during Phase 1 or Phase 2 of the LEAP protocol. Phase 3 (Maintenance) patients should consult their Certified LEAP Therapist for personalized evaluation based on their individual MRT results.
UPC Code: 3206428887835
Assessment Methodology
This assessment was generated using Wellbloom’s automated clinical analysis pipeline. Each ingredient in the product was cross-referenced against the complete MRT 176 panel — including 149 food antigens and 27 chemical additives. Ingredient-to-panel mapping uses direct matching, derivative identification (e.g., ‘whey’ maps to Cow’s Milk), and chemical compound recognition. Hidden trigger sources such as ‘natural flavors’ and ‘spices’ are flagged as unknown variables requiring individual verification.
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Coconut is tested as an individual substance on the MRT panel. Found as coconut oil, coconut milk, coconut cream, and coconut flour — all common substitutes in dairy-free and paleo diets.
Green pea is an MRT-tested legume increasingly used as pea protein in plant-based meats, protein powders, and dairy alternatives. Also found in soups and frozen vegetable blends.
Strawberry is an MRT-tested fruit found in yogurts, ice cream, jams, and flavored beverages. Also appears as "natural strawberry flavor" in many processed foods.
Cane sugar sensitivity is specific to sugarcane-derived sweeteners and is distinct from glucose intolerance. Look for it in ingredient lists as sucrose, cane juice, or turbinado sugar.
Tapioca (cassava-derived starch) is MRT-tested. Increasingly used as a gluten-free thickener, in boba tea, puddings, and as modified food starch. Common in allergen-free baking.
What This Means For Your Diet
With 6 identified triggers, this product has a high concentration of MRT-tested substances. The probability that at least one of these triggers is reactive on your personal panel is statistically significant.
This product is not recommended during Phase 1 (Elimination) or Phase 2 (Reintroduction). It may only be considered during Phase 3 (Maintenance) after your Certified LEAP Therapist has confirmed that all 6 substances scored Green on your individual MRT results.
Products with 3 or more MRT panel triggers require individualized evaluation. Do not attempt to self-assess — your CLT has the clinical training to weigh multiple reactive substances and potential cross-reactivity.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners